Suppr超能文献

蛋白尿能否预测2型糖尿病和糖尿病肾病患者的肾脏预后?

COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?

作者信息

Wang J L, Sun Y, Wang Y, Wu Y, Liu F

机构信息

West China Hospital of Sichuan University, Division of Nephrology, Chengdu, China.

Mianyang Central Hospital, Division of Nephrology, Mianyang, China.

出版信息

Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):29-34. doi: 10.4183/aeb.2022.29.

Abstract

AIMS

This study investigated the relationship between proteinuria levels, clinicopathological features, and renal prognoses in Chinese patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN).

METHODS

Three hundred patients with T2DM and biopsy-proven DN were enrolled. Patients were stratified by 24-h proteinuria levels: Group 1:≤1g/24h); Group 2:1-3g/24h; and Group 3:≥3g/24h. Renal outcomes were defined as having reached end-stage renal disease (ESRD). The proteinuria level's influence on the renal outcomes was evaluated using Cox regression analysis.

RESULTS

Among subgroups stratified by proteinuria levels, systolic blood pressure, serum creatinine, BUN, cholesterol, DR and hypertension incidence, the incidences of patients who progressed to ESRD were the lowest in group 1 (P<0.05). However, eGFR, serum albumin and hemoglobin were highest in group 1. Patients with higher proteinuria levels had much lower five-year renal survival rates. Univariate analyses revealed that higher proteinuria levels were significant clinical predictors of renal prognosis (P<0.05), although they were not independent risk factors for progression to ESRD in the multivariate Cox proportional hazard analysis (P>0.05).

CONCLUSIONS

The higher the level of proteinuria, the lower the 5-year renal survival rate of DN patients, but there was no significant correlation between proteinuria level and 5-year renal survival rate. Other factors in the proteinuria group may have more significant effects on the 5-year renal survival rate, such as lower baseline eGFR, serum albumin, hemoglobin and higher cholesterol, higher incidences of DR and more severe lesions.

摘要

目的

本研究调查了中国2型糖尿病(T2DM)和糖尿病肾病(DN)患者蛋白尿水平、临床病理特征与肾脏预后之间的关系。

方法

纳入300例经活检证实为DN的T2DM患者。根据24小时蛋白尿水平将患者分层:第1组:≤1g/24小时;第2组:1 - 3g/24小时;第3组:≥3g/24小时。肾脏结局定义为达到终末期肾病(ESRD)。采用Cox回归分析评估蛋白尿水平对肾脏结局的影响。

结果

在按蛋白尿水平分层的亚组中,收缩压、血清肌酐、尿素氮、胆固醇、糖尿病视网膜病变(DR)和高血压发病率方面,进展至ESRD的患者发生率在第1组中最低(P<0.05)。然而,估算肾小球滤过率(eGFR)、血清白蛋白和血红蛋白在第1组中最高。蛋白尿水平较高的患者五年肾脏生存率低得多。单因素分析显示较高的蛋白尿水平是肾脏预后的显著临床预测因素(P<0.05),尽管在多变量Cox比例风险分析中它们不是进展至ESRD的独立危险因素(P>0.05)。

结论

蛋白尿水平越高,DN患者的五年肾脏生存率越低,但蛋白尿水平与五年肾脏生存率之间无显著相关性。蛋白尿组中的其他因素可能对五年肾脏生存率有更显著影响,如较低的基线eGFR、血清白蛋白、血红蛋白以及较高的胆固醇、较高的DR发生率和更严重的病变。

相似文献

1
COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?
Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):29-34. doi: 10.4183/aeb.2022.29.
4
Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
Ren Fail. 2018 Nov;40(1):243-251. doi: 10.1080/0886022X.2018.1456453.
5
Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
Int Urol Nephrol. 2021 Jun;53(6):1161-1170. doi: 10.1007/s11255-020-02710-9. Epub 2021 Jan 3.
6
Severe 25-Hydroxyvitamin D Deficiency May Predict Poor Renal Outcomes in Patients With Biopsy-Proven Diabetic Nephropathy.
Front Endocrinol (Lausanne). 2022 May 4;13:871571. doi: 10.3389/fendo.2022.871571. eCollection 2022.
7
Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
J Diabetes Complications. 2017 Jan;31(1):114-121. doi: 10.1016/j.jdiacomp.2016.10.024. Epub 2016 Oct 26.
8
The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy.
J Diabetes Res. 2019 Feb 17;2019:7825804. doi: 10.1155/2019/7825804. eCollection 2019.
9
Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
Diabetes Res Clin Pract. 2018 Jul;141:1-9. doi: 10.1016/j.diabres.2018.04.025. Epub 2018 Apr 21.

本文引用的文献

2
3
Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):486-493. doi: 10.1016/j.ijrobp.2017.04.003. Epub 2017 Apr 11.
4
Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2032-2045. doi: 10.2215/CJN.11491116. Epub 2017 May 18.
5
Abridged for Primary Care Providers.
Clin Diabetes. 2017 Jan;35(1):5-26. doi: 10.2337/cd16-0067.
6
Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
J Diabetes Complications. 2017 Jan;31(1):114-121. doi: 10.1016/j.jdiacomp.2016.10.024. Epub 2016 Oct 26.
7
US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014.
8
Risk of mortality associated to chronic kidney disease in patients with type 2 diabetes mellitus: a 13-year follow-up.
Nefrologia. 2015;35(5):487-92. doi: 10.1016/j.nefro.2015.05.025. Epub 2015 Jul 8.
9
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.
J Am Soc Nephrol. 2015 Aug;26(8):1765-76. doi: 10.1681/ASN.2015010006. Epub 2015 Mar 25.
10
Biomarkers in diabetic nephropathy: Present and future.
World J Diabetes. 2014 Dec 15;5(6):763-76. doi: 10.4239/wjd.v5.i6.763.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验